Nikolaos Patikas

Nikolaos Patikas

Auto-generated profile, based on publicly available information

Nikolaos Patikas

Brigham and Women's Hospital 6

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Cell Reports
Verified
Journal Article
Open access
HFHugo J.R. Fernandes
Hugo J.R. Fernandes
NPNikolaos Patikas
Nikolaos Patikas
SFStefanie Foskolou
Stefanie Foskolou
SFSarah F. Field
Sarah F. Field
JPJong-Eun Park
Jong-Eun Park
EMEmmanouil Metzakopian
Emmanouil Metzakopian
The advent of induced pluripotent stem cell (iPSC)-derived neurons has revolutionized Parkinson's disease (PD) research, but single-cell transcriptomic analysis suggests unresolved cellular heterogeneity within these models. Here, we perform the largest single-cell transcriptomic study of human iPSC-derived dopaminergic neurons to elucidate gene expression dynamics in response to cytotoxic and genetic stressors. We identify multiple neuronal subtypes with transcriptionally distinct profiles and differential sensitivity to stress, highlighting cellular heterogeneity in dopamine in vitro models. We validate this disease model by showing robust expression of PD GWAS genes and overlap with postmortem adult substantia nigra neurons. Importantly, stress signatures are ameliorated using felodipine, an FDA-approved drug. Using isogenic SNCA-A53T mutants, we find perturbations in glycolysis, cholesterol metabolism, synaptic signaling, and ubiquitin-proteasomal degradation. Overall, our study reveals cell type-specific perturbations in human dopamine neurons, which will further our understanding of PD and have implications for cell replacement therapies.

16 February 2024 in Nature Methods
Verified
Journal Article
Closed access
PDF file
JPJulianus Pfeuffer
Julianus Pfeuffer
CBChris Bielow
Chris Bielow
SWSamuel Wein
Samuel Wein
KJKyowon Jeong
Kyowon Jeong
ENEugen Netz
Eugen Netz
TSTimo Sachsenberg
Timo Sachsenberg

30 May 2023 in The EMBO Journal
Verified
Journal Article
Open access
JLJulie Qiaojin Lin
Julie Qiaojin Lin
DKDeepak Khuperkar
Deepak Khuperkar
SPSofia Pavlou
Sofia Pavlou
SMStanislaw Makarchuk
Stanislaw Makarchuk
NPNikolaos Patikas
Nikolaos Patikas
GMGiovanna R Mallucci
Giovanna R Mallucci
Enhanced expression of the cold‐shock protein RNA binding motif 3 (RBM3) is highly neuroprotective both in vitro and in vivo . Whilst upstream signalling pathways leading to RBM3 expression have been described, the precise molecular mechanism of RBM3 cold induction remains elusive. To identify temperature‐dependent modulators of RBM3, we performed a genome‐wide CRISPR‐Cas9 knockout screen using RBM3‐reporter human iPSC‐derived neurons. We found that RBM3 mRNA and protein levels are robustly regulated by several splicing factors, with heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) being the strongest positive regulator. Splicing analysis revealed that moderate hypothermia significantly represses the inclusion of a poison exon, which, when retained, targets the mRNA for nonsense‐mediated decay. Importantly, we show that HNRNPH1 mediates this cold‐dependent exon skipping via its thermosensitive interaction with a G‐rich motif within the poison exon. Our study provides novel mechanistic insights into the regulation of RBM3 and provides further targets for neuroprotective therapeutic strategies.

2 June 2023 in Neuroscience Research
Verified
Journal Article
Open access
NPNikolaos Patikas
Nikolaos Patikas
RARizwan Ansari
Rizwan Ansari
EMEmmanouil Metzakopian
Emmanouil Metzakopian
Three-dimensional(3D) brain organoids provide a platform to study brain development, cellular coordination, and disease using human tissue. Here, we generate midbrain dopaminergic(mDA) organoids from induced pluripotent stem cells(iPSC) from healthy and Parkinson's Disease(PD) donors and assess them as a human PD model using single-cell RNAseq. We characterize cell types in our organoid cultures and analyze our model's Dopamine (DA) neurons using cytotoxic and genetic stressors. Our study provides the first in-depth, single-cell analysis of SNCA triplication DA neurons and shows evidence for molecular dysfunction in oxidative phosphorylation, translation, and ER protein-folding in these cells. We perform an in-silico identification of rotenone-sensitive DA neurons and characterization of corresponding transcriptomic profiles associated with synaptic signalling and cholesterol biosynthesis. Finally, we show a novel chimera organoid model from healthy and PD iPSCs allowing the study of DA neurons from different individuals within the same tissue.

15 October 2025 in Nature Immunology
Verified
Journal Article
Open access
PDF file
CPCamilla Panetti
Camilla Panetti
RDRahel Daetwyler
Rahel Daetwyler
AMAnja Moncsek
Anja Moncsek
NPNikolaos Patikas
Nikolaos Patikas
AAAndreas Agrafiotis
Andreas Agrafiotis
NJNicole Joller
Nicole Joller
The co-inhibitory receptor TIGIT suppresses excessive immune responses in autoimmune conditions while also restraining antitumor immunity. In viral infections, TIGIT alone does not affect viral control but has been shown to limit tissue pathology. However, the underlying mechanisms are incompletely understood. Here we found TIGIT + T cells to express not only an immunoregulatory gene signature but also a tissue repair gene signature. Specifically, after viral infection, TIGIT directly drives expression of the tissue growth factor amphiregulin (Areg), which is strongly reduced in the absence of TIGIT. We identified regulatory T (T reg ) cells, but not CD8 + T cells, as the critical T cell subset mediating these tissue-protective effects. In T reg cells, TIGIT engagement after T cell antigen receptor stimulation induces the transcription factor Blimp-1, which then promotes Areg production and tissue repair. Thus, we uncovered a nonclassical function of the co-inhibitory receptor TIGIT, wherein it not only limits immune pathology by suppressing the immune response but also actively fosters tissue regeneration by inducing the tissue growth factor Areg in T cells.

11 March 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
EWEmma L. Wilson
Emma L. Wilson
YYYizhou Yu
Yizhou Yu
NLNuno S. Leal
Nuno S. Leal
JWJames A. Woodward
James A. Woodward
NPNikolaos Patikas
Nikolaos Patikas
EMEmmanouil Metzakopian
Emmanouil Metzakopian
Organelles form membrane contact sites between each other, allowing for the transfer of molecules and signals. Mitochondria-endoplasmic reticulum (ER) contact sites (MERCS) are cellular subdomains characterized by close apposition of mitochondria and ER membranes. They have been implicated in many diseases, including neurodegenerative, metabolic, and cardiac diseases. Although MERCS have been extensively studied, much remains to be explored. To uncover novel regulators of MERCS, we conducted a genome-wide, flow cytometry-based screen using an engineered MERCS reporter cell line. We found 410 genes whose downregulation promotes MERCS and 230 genes whose downregulation decreases MERCS. From these, 29 genes were selected from each population for arrayed screening and 25 were validated from the high population and 13 from the low population. GET4 and BAG6 were highlighted as the top 2 genes that upon suppression increased MERCS from both the pooled and arrayed screens, and these were subjected to further investigation. Multiple microscopy analyses confirmed that loss of GET4 or BAG6 increased MERCS. GET4 and BAG6 were also observed to interact with the known MERCS proteins, inositol 1,4,5-trisphosphate receptors (IP3R) and glucose-regulated protein 75 (GRP75). In addition, we found that loss of GET4 increased mitochondrial calcium uptake upon ER-Ca2+ release and mitochondrial respiration. Finally, we show that loss of GET4 rescues motor ability, improves lifespan and prevents neurodegeneration in a Drosophila model of Alzheimer’s disease (Aβ42Arc). Together, these results suggest that GET4 is involved in decreasing MERCS and that its loss is neuroprotective.